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Abstract: Our purpose was to evaluate the in vivo endo-
sseous response to three starch-based scaffolds implanted
in rats (n ¼ 54). We implanted the three scaffold groups;
a 50/50 (wt %) blend of corn starch and ethylene-vinyl
alcohol (SEVA-C), the same composition coated with a
biomimetic calcium phosphate (Ca-P) layer (SEVA-C/
CaP), and a 50/50 (wt %) blend of corn starch and cellu-
lose acetate (SCA), all produced by extrusion with blow-
ing agents, into distal femurs proximal to the epiphyseal
plate, for 1, 3, or 6 weeks. Our results showed that at
1 week considerable reparative bone formed around all
scaffold groups, although the bone was separated from
the scaffold by an intervening soft tissue interfacial zone
that comprised two distinct compartments: the surface of
the scaffold was occupied by multinucleate giant cells
and the compartment between these cells and the sur-
rounding bone was occupied by a streaming ﬁbrous-like
tissue. The extracellular matrix of the latter was continu-
ous with the extracellular bone matrix itself, labeled posi-
tively for osteocalcin and appeared mineralized by back-
scattered electron imaging. All three scaffolds showed a
similar tissue response, with the soft tissue interface
diminishing with time. No bone contact was observed
with SEVA-C at any time point, only transitory bone con-
tact was observed with SEVA-C/CaP at 3 weeks, but
SCA exhibited direct bone contact at 6 weeks where
56.23 6 6.46% of the scaffold surface was occupied by
bone. We conclude that all materials exhibited a favor-
able bony response and that the rapidly forming initial
‘‘connective tissue’’ seen around all scaffolds was a very
early form of bone formation.  2006 Wiley Periodicals,
Inc. J Biomed Mater Res 80A: 983–989, 2007
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INTRODUCTION
Contrary to biomaterials approaches, most tissue
engineering strategies are reliant upon the use of a
temporary biodegradable scaffold,1 the ideal struc-
tural and morphological properties of which have
been thoroughly reviewed elsewhere.2–4
We have, since 1995, been developing a series of
starch-based polymeric systems for a range of bio-
medical applications, including bone tissue engineer-
ing scaffolding.5,6 Starch is a polyssacharide com-
prizing a-D-glucose units, which can be organized to
form two distinct molecules, amylase and amylopec-
tin.7 A possible advantage of using polyssacharide-
based biomaterials is that they may act as analogs of
polyssacharides present in vivo and adopt their
roles.8 These starch-based polymeric systems are
commonly blended with thermoplastic polymers
such as cellulose acetate (CA) or ethylene-vinyl al-
cohol (EVOH), to better resist thermomechanical
degradation, and make them less brittle and more
easily processed.7 Starch, as a naturally occurring
material obviates some of the drawbacks of the syn-
thetic aliphatic polyesters, such as poly(lactic acid),
poly(glycolic acid), poly(caprolactone), and their
copolymers, which release degradation products, in-
cluding acidic by-products, that may trigger an
inﬂammatory response and jeopardize integration by
the host tissue.9,10 In fact previous work conducted
Correspondence to: A.J. Salgado; e-mail: asalgado@ecsaude.
uminho.pt
Contract grant sponsor: Portuguese Foundation for Sci-
ence and Technology; contract grant number: SFRH/BD/
3139/2000
Contract grant sponsor: Ontario Research and Develop-
ment Challenge Fund
' 2006 Wiley Periodicals, Inc.
by our research group has shown that these materi-
als were biocompatible after in vitro and in vivo
assays (up to 12 weeks)11 and exhibited an improved
response when directly compared to PLA.12 One of
the possible causes of this favorable in vivo response
could be the enzymatic degradation products of these
materials, which are mainly glucose or glucose deriv-
atives,13 although we recognize that longer term de-
gradation studies are necessary to track the biological
sequelae of complete degradation.
In vitro experiments have also shown that the deg-
radation products of starch-based scaffolds are not
harmful to the cells, and human osteoblasts could
populate their surfaces and elaborate extracellular
matrix.14–16 These starch scaffolds were based on
blends of starch with CA or EVOH, and were
obtained by using a methodology based on extrusion
with blowing agents. Previous characterization of
the latter disclosed porosities between 50 and 70%
and pore sizes in the 200–900 mm range,6,15,16 exhi-
biting at the same time a weight loss of about 20%
during the ﬁrst 10 days of in vitro degradation,
degrading at a slower rate thereafter.6
Given these encouraging in vitro results, the objec-
tive of the present work was to evaluate the in vivo
response of three starch-based scaffolds, mentioned
in the previous paragraph. The scaffolds were com-
posed of a blend of starch with EVOH (SEVA-C) or
with CA, and processed, as previously described, by
extrusion with blowing agents.6 A third group of
SEVA-C scaffolds coated with a biomimetic calcium
phosphate (Ca-P) layer was also used as our previous
studies had shown that the functional osteogenic phe-
notype of an osteoblast cell line population was up
regulated by these coatings.16
Our results show that all the tested groups exhib-
ited biocompatible behaviour, as judged by a lack of
a perceived inﬂammatory response, although bone
contacted the SCA material to a greater extent than
the other two materials. We also report that the
apparent ﬁbrous tissue forming rapidly around the
implanted materials positively labeled with a mono-
clonal antibody for osteocalcin, suggesting that this




Scaffolds used in the present work were composed of:
(i) a 50/50 (wt %) blend of corn starch with EVOH (SEVA-
C) or (ii) a 50/50 (wt %) blend of corn starch with CA
(SCA), both obtained from Novamont, Italy. A third group
of scaffolds based on SEVA-C coated with a CaP layer
(SEVA-C/CaP), produced by a biomimetic route, was also
used. Scaffolds were obtained through processing by
extrusion with blowing agents, as previously described.6
Brieﬂy, the polymers were previously mixed, with 1 and
2% (wt %) of a solid citric acid-based blowing agent
(BIH40, Clariant) for SEVA-C and SCA respectively, in a
biaxial rotating drum. This mixture was then extruded in a
Carvex twin-screw extruder with a 12-mm die, after which
the resulting materials were cut in cylinders of *2.3 mm
diameter by 3 mm height.17 For the biomimetic preminer-
alization of the SEVA-C scaffolds, samples were ﬁrst
soaked in a commercially available sodium silicate solution
(Sigma Aldrich) for 24 h, after which samples were
allowed to dry and immersed in a simulated body ﬂuid
solution for 14 days (20 scaffolds/50 mL of solution), as
described by Oliveira et al.18
In vivo studies
Implantation procedure
Young male Wistar rats (n ¼ 54) with a body weight of
125–150 g were purchased from Charles River (Canada),
housed in light- and temperature-controlled rooms, and
fed a standard diet. The maintenance and use of animals
were in accordance with the Canadian Council of Animal
Care Guidelines. Bone defects were drilled bilaterally in
each distal femur, proximal to the epiphyseal plate, of ev-
ery rat. The defects were made using a low speed dental
drill (2.3 mm in diameter) with copious saline irrigation.
Previously cut scaffolds were then press ﬁt into the
defects. Empty defects with no ﬁlling scaffold/material
were used as controls.
Histological processing
Animals were sacriﬁced after 1, 3, and 6 weeks (n ¼ 18/
week), and the femurs (n ¼ 9/group) removed. Femurs
(n ¼ 3/group) were ﬁxed in neutral formalin, decalciﬁed
in a 1:1 mixture of 45% formic acid and 20% sodium
citrate, dehydrated, and embedded in parafﬁn. Six-micro-
meter-thick serial sections perpendicular to the long axis
of the implant were cut with a Spencer 820 microtome.
Sections were then stained with Masson’s Trichrome stain,
which employs hematoxylin, anilin blue, and biebrich scar-
let to selectively stain muscle, collagen ﬁbers, ﬁbrin, and
erythrocytes respectively; bone appears blue.19 Bone/scaf-
fold contact was expressed as a percentage of the total
scaffold surface measured in 10 micrographs from two
femurs, using National Institutes of Health (NIH) image
software (http://rsb.info.nih.gov/nih-image/Default.html).
Three samples/group were not decalciﬁed and used for X-
ray, while another 3/group were used for TRAP (tartrate-
resistant acid phosphatase) staining.
Immunohistochemistry
For immunohistochemistry (n ¼ 2/group), samples were
ﬁxed in buffered picrate formaldehyde at 48C for 3 days,
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after which samples were decalciﬁed in a 10% EDTA/4%
NaOH solution for 20 days. Samples were then embedded
in parafﬁn and sectioned as described before. After depar-
aﬁnization sections were washed in PBS and successively
incubated with 0.2% hyalurodinase (Sigma), 2% hydrogen
peroxide (Sigma), and 1% bovine serum albumin (BSA)
(Sigma) with PBS washes in between. Sections were then
incubated with a monoclonal antiosteocalcin antibody
(Takara, Japan) for 16 h in a moisture chamber at 48C, at a
working dilution of 1:500. For the negative controls the
primary antibody was not used, being replaced instead by
PBS. After being washed in PBS, sections were further
incubated with the secondary antibody system (Amersham
Pharmacia Biotech) for 4 h, in the same conditions as pre-
viously described, at a working dilution of 1:200. Visual-
ization of the antibody-enzyme complexes was made
possible by incubating the sections with PBS containing
0.5 mg/mL diaminobenzidine and 0.03% H2O2 (Sigma).
Sections were ﬁnally mounted with glycerin jelly and
observed under a light microscope.
Back-scattered electron imaging
Back-scattered electron imaging was used to observe an
early connective tissue that was being elaborated around
the implanted scaffolds (n ¼ 1/group). Scaffolds were
ﬁxed in neutral formalin, washed for 30 min in running
water, dehydrated, embedded in OsteobedTM resin, plati-
num sputtered and observed by scanning electron micros-
copy (20 kV), in backscattered mode.
RESULTS
All animals recovered uneventfully from the sur-
gery. Histology revealed that all three materials
invoked similar tissue reactions with considerable
reparative bone being present at 1 week, but sepa-
rated from the scaffold surface by an intervening soft
tissue interfacial zone [Fig. 1(A,B)]. This soft tissue
comprised two distinct compartments with the sur-
face of the scaffold material occupied by darkly
stained multinucleate giant cells and the compart-
ment between these cells and the surrounding bone
occupied by a streaming ﬁbrous-like tissue which
stained faintly blue as illustrated in Figure 1(B). This
blue stained extracellular matrix could be easily
traced through the soft tissue compartment to the
bone margin and was continuous with the extracel-
lular bone matrix itself. Speciﬁcally, this matrix was
seen to surround osteoblasts at the limit of the histo-
logically identiﬁable bone matrix [Figure 1(B)]. There
was no evidence of inﬂammatory cells within this
soft tissue.
All three sample materials exhibited a multinu-
cleate giant cell (MGC) response. TRAP staining (not
shown) was negative in all cases. The MGC layer
was seen to be continuous over all available scaffold
surfaces in the SEVA-C [Fig. 1(C)] and SEVA-C/CaP
samples, while only a discontinuous layer of MGCs
was seen in the case of the SCA material. In the case
of the former two materials, some MGCs were still
observed at 6 weeks while in the case of the SCA
scaffolds, the interface was occupied by either bone
or marrow at 6 weeks [Fig. 1(D)]. The cellular com-
position of the interfacial marrow, in contact with
the scaffold surface, was indistinguishable from the
remaining bulk marrow compartment.
With time, as seen in the 3- and 6-week samples,
the amount of reparative bone decreased, as could
be expected in this essentially diaphyseal implanta-
tion site, but the soft tissue interfacial zone also
decreased in width and, in the case of the SCA scaf-
fold was eliminated on some surfaces of the scaffold
resulting in direct bone/scaffold contact [Fig. 1(E)].
Such bone contact was also seen, to a less obvious
extent, in the case of SEVA-C/CaP scaffolds after
3 weeks of implantation, but after 6 weeks there was
no bone contact with this scaffold surface. Thus,
bone contact was only measured in the SCA sam-
ples, at the 6-week time point, as a percentage of
total available linear scaffold surface in a total of
20 micrographs, to be 56.23 6 6.46%. Bone contact
was not seen in the case of SEVA-C samples at any
examination time point.
The soft tissue of the interfacial zone at early heal-
ing times was of particular interest, since the extrac-
ellular matrix appeared to be continuous with that
of the surrounding bone matrix, and was therefore
also examined by immuno-labeling for osteocalcin
and back-scattered electron imaging. The former
revealed that the reparative bone was positive for
osteocalcin, but that some areas of the soft tissue
which were not histologically identiﬁable as bone,
were also labeled [Fig. 2 (B,D,F]. Similarly, BSEI
(Fig. 3) showed that this soft tissue compartment
adjacent to bone contained electron dense strands
continuous with the bony surfaces of similar back-
scattering properties to the bone matrix itself.
DISCUSSION
Our results show that the interfacial tissue zone
was occupied by an initial streaming ﬁbrous tissue,
which contained osteocalcin positive, and mineral-
ized extracellular matrix. This matrix disappeared in
time, particularly in the case of the SCA scaffolds,
without any evidence of cellular remodeling, and the
interface was occupied by bone. We have reported
similar tissue in other rapidly healing bony compart-
ments19 and believe that this may represent an early,
rapidly forming bone matrix similar to that seen in
advancing fronts of intramembraneous bone forma-
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tion. The positive labeling with osteocalcin, and
back-scattered electron imaging, provides further
evidence for this assumption.
Although the healing response to the three scaf-
fold materials employed herein was similar, the dif-
ferences in MGC response would seem to correlate
with previous studies of protein adsorption to these
polymeric surfaces. Thus, our previous work 20 has
shown that SEVA-C-based materials had a more ho-
mogeneous protein coating and higher protein
Figure 1. Histological micrographs (Masson’s Trichrome staining) of (A,B) SEVA-C/CaP after 1, (C) SEVA-C after 3 and
(D,E) SCA after 6 weeks of implantation in rat femora. After 1 week, it was possible to observe the presence of a stream-
ing connective tissue (B) that showed continuity with the surrounding bone trabeculae, and was not present after 6 weeks
of implantation (D). Figure D is a representative example of a SCA scaffold after 6 weeks of implantation. As it can be
observed the scaffold was very well integrated in a very quiescent surrounding marrow, and thus can be considered as
biocompatible. At the same time bone was growing both at the surface and inner pores of the scaffold. When looking at
higher magniﬁcation (E) it was possible to observe that the bone was directly contacting the scaffolds surface (the existing
gap between the scaffold and surrounding bone is an artifact caused by the sectioning of the samples) (B- Bone, C-
Connective Tissue, G- Multinucleated Giant Cells, S- Scaffold. FW ¼ (a,c,d) 3.5 mm, (b) 351.5 mm and (e) 104.6 mm). [Color
ﬁgure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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adsorption rates, when compared to SCA surfaces.
These differences are probably related with the na-
ture of the two different polymeric blends. While
SEVA-C blends are interpenetrating networks, SCA
is a nonmiscible blend, resulting in a different distri-
bution of the starch along the surface of the poly-
meric scaffold. These differences in protein adsorp-
tion may explain why the MGC response to the SCA
samples was different to the SEVA-C scaffolds.
The tissue reaction to SEVA-C/CaP scaffolds was
not what we expected given our previous results
obtained in vitro that have shown that this biomi-
metic coating improved cell adhesion and stimulated
osteogenic cell differentiation, as demonstrated by
increased ALP activity and bone ECM elaboration.16
Nevertheless, the transitory appearance of direct
bone contact at the 3-week time point, and its disap-
pearance by 6 weeks indicates not only a favorable
Figure 2. Immunohistochemistry micrographs of SEVA-C (A,B), SEVA-C/Ca-P (C,D), SCA (E,F) scaffolds implanted in
rat femora after 1 week. H&E sections (A,C,E) are shown to illustrate the peri-implant tissue. Samples from all the tested
groups labelled positive for osteocalcin (B, D, F), indicating that this early form of connective tissue may be a very early
form of bone formation. (B- Bone, C- Connective Tissue, S- Scaffold. FW ¼ A–F) 562.5 mm). [Color ﬁgure can be viewed in
the online issue, which is available at www.interscience.wiley.com.]
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bony response to this material, but also the complete
remodeling of the reparative bone in this healing
compartment and reversion to normal marrow,
which can be expected in this diaphyseal site. How-
ever, it should also be noted that the in vivo environ-
ment is radically different from that found in vitro,
and that in vitro results may not be a predictor of
in vivo behavior. Furthermore, the limited thickness
of the SEVA-C/CaP coating (10 mm) and its partially
amorphous nature may both result in rapid re-
sorption/dissolution rates, as explained by other
authors, 21–23 and thus explain the similarity in our
results with the coated and uncoated SEVA-C scaf-
folds. Nevertheless, it should be pointed out that
although these scaffolds exhibited a MGC response,
they were well integrated in the surrounding mar-
row, indicating a favorable biocompatible response.
Our observations of bone and marrow, contact
with the SCA scaffolds are of interest since this ther-
moplastic biodegradable polymer comprised neither
a ceramic ﬁller nor biomimetic coating. Since direct
bone/scaffold contact was seen, osteoprogenitor cells
must have migrated to the surface of this material,
indicating that these scaffolds have osteoconductive
properties.
CONCLUSIONS
We show that the three different starch-based scaf-
folds (SCA, SEVA-C, and SEVAC/CaP) were well
integrated in the defect site and surrounding mar-
row, indicating their biocompatibility. The major dif-
ferences found between the 3 tested groups were the
degrees of direct bone/scaffold contact, which was
only marked in the case of SCA scaffolds. Further-
more, as a result of positive osteocalcin labeling and
back-scattered electron imaging, the early connective
tissue occupying the bone/scaffold interface can be
characterized as an early form of bone.
The authors thank Susan Carter and Feryal Sarraf, from
the Faculty of Dentistry at the University of Toronto, for
assisting respectively with the surgeries and histological
staining.
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